Literature DB >> 23650407

Phosphatase and tensin homolog deficiency and resistance to trastuzumab and chemotherapy.

Brent N Rexer, Yu Shyr, Carlos L Arteaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23650407     DOI： 10.1200/JCO.2012.48.5243

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.

Authors:  Carlos L Arteaga; Jeffrey A Engelman
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

2.  PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.

Authors:  Howard M Stern; Humphrey Gardner; Tomasz Burzykowski; Wafaa Elatre; Carol O'Brien; Mark R Lackner; Gary A Pestano; Angela Santiago; Ivonne Villalobos; Wolfgang Eiermann; Tadeusz Pienkowski; Miguel Martin; Nicholas Robert; John Crown; Paolo Nuciforo; Valerie Bee; John Mackey; Dennis J Slamon; Michael F Press
Journal:  Clin Cancer Res       Date:  2015-02-03       Impact factor: 12.531

3.  Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy.

Authors:  Muhan Chen; Dawid G Nowak; Lloyd C Trotman
Journal:  Clin Cancer Res       Date:  2014-06-15       Impact factor: 12.531

Review 4.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

5.  CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.

Authors:  Agnieszka K Witkiewicz; Derek Cox; Erik S Knudsen
Journal:  Genes Cancer       Date:  2014-07

Review 6.  The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.

Authors:  Yi-Min Lu; Feng Cheng; Li-Song Teng
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

7.  MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.

Authors:  Leticia De Mattos-Arruda; Giulia Bottai; Paolo G Nuciforo; Luca Di Tommaso; Elisa Giovannetti; Vicente Peg; Agnese Losurdo; José Pérez-Garcia; Giovanna Masci; Fabio Corsi; Javier Cortés; Joan Seoane; George A Calin; Libero Santarpia
Journal:  Oncotarget       Date:  2015-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.